Visit ICON plc at ASCO24, booth 30119 to learn about One Search – ICON plc
Tanja Obradovic shared a post by ICON plc on LinkedIn, adding:
“ASCO204 is almost to start.
As largest Clinical Oncology meeting it is indeed great opportunity to have productive exchange on clinical trial, program, and portfolio development status in light of incoming updates.
ICON team covering both clinical development strategy as well as operational tactics is at the booth 30119 so stopping by is welcomed.”
Quoting ICON plc’s post:
“Approximately 11% of sites failing to recruit a single patient.
Visit us at ASCO24, booth 30119 to learn about One Search, ICON’s award winning, AI-driven site selection tool to help identify the right sites the first time.”
Additional information.
Source: Tanja Obradovic/LinkedIn and ICON plc/LinkedIn
Tanja Obradovic is the Vice President of Oncology Scientific Affairs at ICON PLCh. She has over 20 years of clinical research experience and has led major pharmaceutical companies for 13 years. Her research focuses on small molecules, antibodies, cell and gene therapy, and major immunotherapy of PD1 inhibitors.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023